Hudson Edge Investment Partners’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Hudson Edge Investment Partners’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-6,458	Closed	-$266K	–	148
2015 Q2	$266K	Sell	6,458 -1,945	-23%	-$69.7K	0.01%	133
2015 Q1	$296K	Sell	8,403 -1,902	-18%	-$64.3K	0.01%	135
2014 Q4	$331K	Sell	10,305 -48	-0.5%	-$1.39K	0.01%	133
2014 Q3	$291K	Sell	10,353 -90	-0.9%	-$2.74K	0.01%	134
2014 Q2	$316K	Buy	10,443 +2,263	+28%	+$62.5K	0.01%	128
2014 Q1	$226K	Sell	8,180 -575	-7%	-$15K	0.01%	137
2013 Q4	$224K	Sell	8,755 -1,910	-18%	-$58.9K	0.01%	138
2013 Q3	$319K	Sell	10,665 -335	-3%	-$9.32K	0.01%	126
2013 Q2	$316K	Buy	+11,000	New	+$303K	0.01%	127

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Hudson Edge Investment Partners's BRLI Position: Q3 2015 in Review

Hudson Edge Investment Partners sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 6,458 shares — an estimated $266K sold.

Hudson Edge Investment Partners first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $331K in Q4 2014. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Hudson Edge Investment Partners reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Hudson Edge Investment Partners sold 6,458 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $266K.
Hudson Edge Investment Partners first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Hudson Edge Investment Partners's BIO-REFERENCE LABS INC-NEW- position peaked at $331K in Q4 2014.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Hudson Edge Investment Partners's 13F filing for Q3 2015, filed 10 Nov 2015.